11/22/2024 | Press release | Distributed by Public on 11/22/2024 15:10
Item 1.01 Entry into a Material Definitive Agreement.
On November 20, 2024, ProKidney Corp. (the "Company"), through its wholly owned subsidiary, ProKidney Acquisition Company, LLC, entered into a purchase agreement with Breit SE Industrial Propco NC LP (the "Agreement") to purchase two buildings on adjacent parcels in Winston-Salem, North Carolina, portions of which buildings the Company now occupies pursuant to real estate leases. The two buildings represent total usable space of approximately 180,000 square feet and are expected to support the Company's manufacturing operations for rilparencel, the Company's lead product candidate. Under the Agreement, the Company will pay approximately $22.5 million in cash for the buildings and land. The Agreement contains customary representations. The transaction is expected to close by the end of November 2024, upon satisfaction of customary closing conditions.
The foregoing description of the Agreement is qualified in its entirety by reference to the full text of such agreement, which the Company intends to file as an exhibit to its Annual Report on Form 10-K for the year ended December 31, 2024.